J2428 HCPCS Level II code: Injection, paliperidone palmitate extended release (erzofri), 1 mg
J2428 is the HCPCS code for “Injection, paliperidone palmitate extended release (erzofri), 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2428Injection, paliperidone palmitate extended release (erzofri), 1 mg
Short description: Inj, erzofri, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2428 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Apr 1, 2025
Where J2428 sits
- 1J codesDrugs administered other than orally
- 2Active code J2428Injection, paliperidone palmitate extended release (erzofri), 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2428 mean?
J2428 is the HCPCS code for “Injection, paliperidone palmitate extended release (erzofri), 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2428?
CMS lists J2428’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2428
All J codesJ2406Injection, oritavancin (kimyrsa), 10 mgJ2407Injection, oritavancin (orbactiv), 10 mgJ2410Injection, oxymorphone hcl, up to 1 mgJ2425Injection, palifermin, 50 microgramsJ2426Injection, paliperidone palmitate extended release (invega sustenna), 1 mgJ2427Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mgJ2430Injection, pamidronate disodium, per 30 mgJ2440Injection, papaverine hcl, up to 60 mgJ2460Injection, oxytetracycline hcl, up to 50 mgJ2468Injection, palonosetron hydrochloride (posfrea), 25 microgramsJ2469Injection, palonosetron hcl, 25 mcgJ2470Injection, pantoprazole sodium, 40 mg